Workshop and Q&A October 6th

Strain identifier

BacDive ID: 11698

Type strain: Yes

Species: Haemophilus influenzae

Strain Designation: 680

Culture col. no.: DSM 4690, ATCC 33391, NCTC 8143, JCM 33542, CCUG 23945, CIP 102514

Strain history: CIP 102514 <-- NCTC 8143 <-- A.B. Rosher; UK <-- M. Pittman; NIH, USA; 680.

NCBI tax ID(s): 727 (species)

« Browse strain by BacDive ID »

expand / minimize allblue arrow down

Exclude non-curated data/information

Haemophilus influenzae 680 is a microaerophile, mesophilic bacterium of the family Pasteurellaceae.

  1. mesophilic
  2. microaerophile
  3. 16S sequence
  4. Bacteria
  5. genome sequence
  • Availability in culture collections External linksarrow_down
  • [Ref.: #1685] Culture collection no. DSM 4690, ATCC 33391, NCTC 8143, JCM 33542, CCUG 23945, CIP 102514
    [Ref.: #20218] Associated Passport(s) in StrainInfo 151460, 109254, 109255
    Literature:
    Titlearrow to sort Authorsarrow to sort Journalarrow to sort DOIarrow to sort Yeararrow to sort Mesharrow to sort Topicarrow to sort Topic2arrow to sort
    Identifying the major proteome components of Haemophilus influenzae type-strain NCTC 8143. Link AJ, Hays LG, Carmack EB, Yates JR 3rd Electrophoresis 10.1002/elps.1150180808 1997 Bacterial Proteins/*genetics/*isolation & purification, Electrophoresis, Gel, Two-Dimensional/*methods, *Genome, Bacterial, Haemophilus influenzae/*chemistry/*genetics, Isoelectric Point, Mass Spectrometry/methods, Molecular Weight, Peptide Mapping/*methods Enzymology Genetics *
    Exogenous glutathione completes the defense against oxidative stress in Haemophilus influenzae. Vergauwen B, Pauwels F, Vaneechoutte M, Van Beeumen JJ J Bacteriol 10.1128/JB.185.5.1572-1581.2003 2003 Antioxidants/metabolism, Catalase/drug effects/genetics/metabolism, Cloning, Molecular, Drug Resistance, Microbial/genetics, Escherichia coli/drug effects/genetics, Genetic Complementation Test, Glutathione/*analogs & derivatives/*metabolism/pharmacology, Glutathione Peroxidase/drug effects/genetics/metabolism, Haemophilus influenzae/drug effects/*physiology, Inactivation, Metabolic, Mutation, *Oxidative Stress, Phagocytosis/drug effects, Pyruvaldehyde/pharmacology, S-Nitrosoglutathione/pharmacology, Sulfur/metabolism, tert-Butylhydroperoxide/pharmacology Metabolism Pathogenicity *
    In vitro activities of piperacillin against beta-lactamase-negative ampicillin-resistant Haemophilus influenzae. Morikawa Y, Kitazato M, Mitsuyama J, Mizunaga S, Minami S, Watanabe Y Antimicrob Agents Chemother 10.1128/AAC.48.4.1229-1234.2004 2004 Ampicillin Resistance/*genetics, Bacterial Proteins/metabolism, Carrier Proteins/metabolism, Cefotaxime/pharmacology, Ceftriaxone/pharmacology, Cephalosporins/pharmacology, Haemophilus influenzae/*drug effects/enzymology/genetics, Hexosyltransferases/metabolism, Humans, Kinetics, Meningitis, Haemophilus/microbiology, Microbial Sensitivity Tests, Muramoylpentapeptide Carboxypeptidase/metabolism, Penicillin-Binding Proteins, Penicillins/*pharmacology, Peptidyl Transferases/metabolism, Piperacillin/*pharmacology, beta-Lactamases/*genetics Metabolism Enzymology *

Change proposal

You found an error in BacDive? Please tell us about it!

Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.

Field you want to change:


CAPTCHAReload captcha

Change proposal

Successfully sent